News

Deal Announcements

Cardax Pharma Collects Venture Capital Funding

Monday, March 16, 2015 5:46:00 AM PDT | VentureDeal
   Honolulu, Hawaii  --  Cardax Pharmaceuticals has landed $290,000 in new equity funding, according to an SEC regulatory filing.

Cardax is developing small molecule compounds that impact inflammatory pathways affected by TNF-alpha.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

The company has previously raised in excess of $6 million in financing since 2010.

Cardax is still seeking $3.2 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1